Does Stent Externalization Matter in Robotic Pancreaticoduodenectomy? A Risk‐Stratified Comparison of Internal and External Pancreatic Stenting
Journal of Surgical Oncology · 2026-11-09
DOI: 10.1002/jso.70439 ↗Abstract
ABSTRACT Background Postoperative pancreatic fistula (POPF) remains a significant source of morbidity following pancreaticoduodenectomy (PD), and whether internal or external stenting better mitigates POPF after robotic PD (RPD) remains unclear. Methods A retrospective review was conducted of patients who underwent RPD with internalized or externalized pancreatic duct stents at a single academic institution (2020–2026). POPF was graded by ISGPS criteria, with risk stratified by Fistula Risk Score (FRS) and Alternative FRS (A‐FRS). Ninety‐day outcomes were recorded. Results Of 182 patients, 83 (45.6%) received an externalized stent. Age, sex, BMI, and PDAC proportion were similar between internal and external stent groups, as was fistula risk (74.7% vs. 71.1% intermediate/high risk) (all p > 0.05). Overall POPF rate was nearly identical (18.2% vs. 18.1%; p = 0.985), with most fistulas (73.5%) being biochemical leaks and no Grade C fistulas. Among low/intermediate A‐FRS patients, clinically‐relevant POPF rates were comparable (2.6% vs. 2.9%; p = 0.994). In high A‐FRS patients, external stenting was associated with significantly fewer clinically‐relevant POPFs (0.0% vs. 21.7%) and more biochemical leaks (35.7% vs. 8.7%, p = 0.04). External stenting did not increase length of stay or readmission. Conclusions In high fistula‐risk RPD patients, external stenting was associated with fewer clinically‐relevant POPFs, suggesting externalization may prevent progression to clinically‐relevant POPF.
EUVIMED